At 8.4% CAGR, Europe Home Healthcare Market is Projected to be Worth US$ 1,68,108.00 Million by 2031, says The Insight Partners
According to The Insight Partners’ research, the Europe home healthcare market was valued at US$ 95,565.78 million in 2024 and is expected to reach US$ 1,68,108.00 million by 2031, registering a CAGR of 8.4% from 2024 to 2031. Cost-effectiveness of home healthcare and growing government support for home healthcare are among the critical factors attributed to driving the Europe home healthcare market growth.
With the global population aging, governments across the globe are acknowledging the significance of delivering comprehensive healthcare services to senior citizens, which include care within the home. This awareness is leading to various initiatives and programs focused on enhancing the quality of life for older adults and encouraging healthy aging. For instance, across the European Union, targeted initiatives have been underway to enhance healthcare services for the growing population of older adults. The Hungarian government launched a US$ 229 million remote health monitoring program for individuals aged 65 and above. This initiative, funded by the EU's Recovery and Resilience Facility, aims to reduce hospital stays and healthcare costs by providing continuous medical care at home. The program includes the deployment of wearable sensory devices for over 1.5 million elderly citizens, enabling 24-hour surveillance and emergency response services. The initiative is set to be fully implemented by the end of 2025. Also, in the UK, the 2025‑2026 Local Authority Better Care Grant is set at £2,640 million, a ring‑fenced fund to support local health & social care services to help people stay at home rather than being admitted to hospital or care homes. Such initiatives benefit the well-being of seniors and increase the demand for home healthcare services.
On the contrary, data privacy vulnerabilities hamper the growth of the Europe home healthcare market.
Based on services, the Europe home healthcare market is segmented into skilled nursing care, physical therapy, rehabilitation therapy, speech therapy, and others. The skilled nursing care segment held 48.6% share of Europe home healthcare market share in 2024, amassing US$ 46,399.24 million. It is projected to garner US$ 84,423.97 million by 2031 to register 8.9% CAGR during 2024–2031.
By type, the Europe home healthcare market is segmented into therapeutic, diagnostic, and mobility assist. The therapeutic segment held 43.2% share of Europe home healthcare market share in 2024, amassing US$ 41,305.25 million. It is projected to garner US$ 71,787.58 million by 2031 to register 8.2% CAGR during 2024–2031.
By indication, the Europe home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular disorders, wound care, diabetes, and other. The respiratory diseases segment held 22.8% share of Europe home healthcare market share in 2024, amassing US$ 21,754.72 million. It is projected to garner US$ 38,573.17 million by 2031 to register 8.5% CAGR during 2024–2031.
Based on country, the Europe home healthcare market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 31.5% share of Europe home healthcare market in 2024. It was assessed at US$ 30,056.28 million in 2024 and is likely to hit US$ 54,576.36 million by 2031, registering a CAGR of 8.9% during 2024–2031.
Key players operating in the home healthcare market include Enhabit Home Health & Hospice, Apollo HomeCare, Cura Mexico, Koninklijke Philips NV, LHC Group Inc, BAYADA Home Health Care, Mears Group Plc, Abbott Care, Amedisys Inc, Kindred Healthcare LLC, and CenterWell Home Healths, among others.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com